Dermatologic Oncology Update

Nonmelanoma Skin Cancers — A Roundtable Discussion on the Multidisciplinary Management of Cutaneous Squamous Cell and Basal Cell Carcinomas

Dr Nikhil I Khushalani from Moffitt Cancer Center in Tampa, Florida, Dr Soo J Park from the UC San Diego Moores Cancer Center in California, Dr Vishal Anil Patel from the GW Cancer Center in Washington, DC, and Dr Evan Wuthrick, also from Moffitt Cancer Center, discusses recent updates on available and novel treatment strategies for nonmelanoma skin cancers. CME information and select publications here [https://www.researchtopractice.com/NonmelanomaSkinThinkTank2025].

Soft Tissue Sarcoma and Other Connective Tissue Neoplasms — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual Meeting

Dr Rashmi Chugh from Rogel Comprehensive Cancer Center in Ann Arbor, Michigan, and Dr Mrinal Gounder from Memorial Sloan Kettering Cancer Center in New York, New York, summarize major clinical findings presented at the 2025 ASCO Annual Meeting for patients with soft tissue sarcoma and other connective tissue neoplasms.  CME information and select publications here [https://www.researchtopractice.com/ASCO2025/STS].

Sarcoma and Other Connective Tissue Neoplasms — Fourth Annual National General Medical Oncology Summit

Clinical investigators discuss available data guiding the management of sarcoma and other connective tissue neoplasms.   CME information and select publications here [https://www.researchtopractice.com/GMO25].

Neurofibromatosis Type 1 Plexiform Neurofibromas — An interview with Dr Christopher L Moertel

Dr Christopher L Moertel from the University of Minnesota in Minneapolis discusses the clinical presentation of and optimal management strategies for plexiform neurofibromas and malignancies associated with neurofibromatosis type 1.  CME information and select publications here [https://www.researchtopractice.com/OncologyTodayNF24].

Oncology Today with Dr Neil Love: Optimizing the Management of Tenosynovial Giant Cell Tumor

Dr Emanuela Palmerini from the IRCCS Istituto Ortopedico Rizzoli in Bologna, Italy, discusses the current and future clinical treatment of tenosynovial giant cell tumor.